Investing Profile

Krishna Polu

VCInvestor
Principal at Red Tree Venture Capital
redtreevc.com/team/San Francisco Bay Area
Photo of Krishna Polu, Principal at Red Tree Venture Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
511 CONNECTIONS
Stanford University Graduate School of Business Network
297 CONNECTIONS
Harvard Medical School Network
20 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
Bicara Therapeutics
Series CDec 2023$170M
Series BMar 2023$110M
$270M
Co-investors: Ketan Patel (F-Prime Capital Partners), Jake Simson (RA Capital)
Executive in Residence Bioqube Ventures2023 - Present
Chief Executive Officer Commit Biologics2023 - Present
Director Board of Directors Sardona Therapeutics2023 - Present
Director Board of Directors Bicara Therapeutics2022 - 2023
Principal Red Tree Venture Capital2021 - 2023
Member Board Of Directors Frazier Lifesciences Acquisition Corporation2020 - 2022
EVP of R&D and Chief Medical Officer Equillium, Inc.2018 - 2021
Interim CEO Scout Bio2018 - 2018
Entrepreneur In Residence Frazier Healthcare Partners2017 - 2018
Chief Medical Officer Raptor Pharmaceuticals2015 - 2016
Chief Medical Officer CytomX Therapeutics2013 - 2014
Vice President, Clinical Development Affymax2009 - 2013
Executive Director, Clinical Development Amgen2005 - 2009
Stanford University Graduate School of Business Certificate Directors Consortium
Harvard Medical School Fellowship in Nephrology
University of Colorado Anschutz Medical Campus Residency in Internal Medicine
The University of Texas Medical School at San Antonio MD
Stanford University BA Human Biology